Prestige Consumer Healthcare (PBH) EBT (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly EBT of $61.8 million for Q4 2025, down 22.88% year-over-year from $80.2 million in Q4 2024, and down 10.59% quarter-over-quarter from $69.1 million in Q3 2025.
Prestige Consumer Healthcare (PBH) EBT (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's EBT history runs 16 years deep, the most recent figure standing at $61.8 million for Q4 2025.
- In Q4 2025, EBT fell 22.88% year-over-year to $61.8 million; the TTM figure through Dec 2025 stood at $266.7 million (down 3.92% YoY), while the FY2025 annual figure was $284.2 million, up 2.96% from the prior year.
- EBT for Q4 2025 stood at $61.8 million, down from $69.1 million in the prior quarter.
- The five-year high for EBT was $80.2 million in Q4 2024, with the low at -$299.5 million in Q1 2023.
- The 5-year median for EBT is $67.7 million (2022), against an average of $48.1 million.
- The sharpest annual moves came in 2023 and 2024: EBT tumbled 591.3% in 2023, then soared 122.48% in 2024.
- Prestige Consumer Healthcare's EBT stood at $65.5 million in 2021, then gained by 4.01% to $68.1 million in 2022, then advanced by 2.14% to $69.6 million in 2023, then increased by 15.21% to $80.2 million in 2024, then slipped by 22.88% to $61.8 million in 2025.
- Business Quant data shows PBH's EBT at $61.8 million in Q4 2025, $69.1 million in Q3 2025, and $61.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -455.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 372.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -64.00 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 162.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 56.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 61.81 Mn |
| Sep 30, 2025 | 69.13 Mn |
| Jun 30, 2025 | 61.78 Mn |
| Mar 31, 2025 | 73.96 Mn |
| Dec 31, 2024 | 80.15 Mn |
| Sep 30, 2024 | 71.66 Mn |
| Jun 30, 2024 | 58.41 Mn |
| Mar 31, 2024 | 67.32 Mn |
| Dec 31, 2023 | 69.58 Mn |
| Sep 30, 2023 | 70.42 Mn |
| Jun 30, 2023 | 68.71 Mn |
| Mar 31, 2023 | -299.52 Mn |
| Dec 31, 2022 | 68.12 Mn |
| Sep 30, 2022 | 66.59 Mn |
| Jun 30, 2022 | 70.90 Mn |
| Mar 31, 2022 | 60.97 Mn |
| Dec 31, 2021 | 65.49 Mn |
| Sep 30, 2021 | 59.63 Mn |
| Jun 30, 2021 | 76.37 Mn |
| Mar 31, 2021 | 40.37 Mn |